LITFULO 50 mg, gélule — plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 30 gélule(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930279724
  • CIP7 3027972
  • CIS 62624259
  • Registration number EU/1/23/1755

What the source publishes

Holder
PFIZER EUROPE MA EEIG (BELGIQUE)
Active ingredients
RITLÉCITINIB, TOSYLATE DE RITLÉCITINIB
Form
gélule
Package
plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 30 gélule(s)
Routes
orale
Administrative status
authorised
Supply regime
prescription réservée aux spécialistes et services PEDIATRIE ; médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services MEDECINE INTERNE ; prescription réservée aux spécialistes et services DERMATOLOGIE ; liste I
Marketing status
Déclaration de commercialisation
Authorised on
2023-09-15
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930279724
{
  "cis": "62624259",
  "cip7": "3027972",
  "form": "gélule",
  "name": "LITFULO 50 mg, gélule — plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 30 gélule(s)",
  "cip13": "3400930279724",
  "holder": "PFIZER EUROPE MA EEIG (BELGIQUE)",
  "routes": [
    "orale"
  ],
  "holders": [
    "PFIZER EUROPE MA EEIG (BELGIQUE)"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "972.76",
  "authorisedOn": "2023-09-15",
  "compositions": [
    {
      "name": "RITLÉCITINIB",
      "nature": "FT",
      "strength": "50 mg",
      "linkageNumber": "1",
      "substanceCode": "59323",
      "dosageReference": "une gélule",
      "pharmaceuticalElement": "gélule"
    },
    {
      "name": "TOSYLATE DE RITLÉCITINIB",
      "nature": "SA",
      "strength": null,
      "linkageNumber": "1",
      "substanceCode": "69083",
      "dosageReference": null,
      "pharmaceuticalElement": "gélule"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "prescription réservée aux spécialistes et services PEDIATRIE ; médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services MEDECINE INTERNE ; prescription réservée aux spécialistes et services DERMATOLOGIE ; liste I",
  "dispensingFee": "1.02",
  "medicinePrice": "971.74",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "LITFULO 50 mg, gélule",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 30 gélule(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "30 %"
  ],
  "marketingDeclaredOn": "2024-10-17",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": true,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "RITLÉCITINIB",
    "TOSYLATE DE RITLÉCITINIB"
  ],
  "authorisationProcedure": "Procédure centralisée",
  "prescriptionConditions": [
    "prescription réservée aux spécialistes et services PEDIATRIE",
    "médicament nécessitant une surveillance particulière pendant le traitement",
    "prescription réservée aux spécialistes et services MEDECINE INTERNE",
    "prescription réservée aux spécialistes et services DERMATOLOGIE",
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": "EU/1/23/1755",
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930279724"